All articles tagged with #evidence based
Neurologist Kathleen Digre reviews four popular internet migraine hacks (salt under the tongue, sucking ginger, vapor-rub on the neck, and hot-water foot soaks), finding little to no solid evidence they relieve pain; ginger may help nausea, hydration is key, and relaxation can ease symptoms, but for true relief you should rely on evidence-backed treatments rather than viral cures.
A large review of 113 trials (about 8,000 participants) finds collagen can modestly improve skin hydration and elasticity and reduce osteoarthritis joint pain with consistent, long-term use, plus small gains in lean mass. It does not enhance post-exercise recovery or tendon properties, and effects on blood pressure, cholesterol, blood sugar, or oral health are inconclusive. Collagen is not a miracle cure and should be used with realistic expectations and medical guidance.
Most workout supplements on the market lack solid evidence of effectiveness and may contain harmful additives, but a short list endorsed by the International Olympic Committee includes those with proven benefits for health and performance.
The World Health Organization (WHO) has held its first summit dedicated to traditional medicine, aiming to explore how to integrate traditional medicines into conventional healthcare and collaborate scientifically to understand their use more thoroughly. The summit, co-hosted by the Indian government, brings together participants from various regions, Indigenous communities, traditional-medicine practitioners, and policy, data, and science specialists. While some researchers are skeptical about the summit's outcomes, others believe it is an opportunity to gather evidence for traditional healing systems and improve the quality and quantity of research in this field. The WHO emphasizes the need for rigorous scientific validation and global standards for traditional medicines, while also recognizing the importance of cultural and contextual considerations in holistic interventions.
FDA chief Robert Califf told biotech leaders that drug prices in the US are too high, despite the drug industry's opposition to new mechanisms that could limit how much governments or insurers pay for certain new medicines. Califf has spent much of his career working on new ways of generating decisive evidence for therapies and other medical interventions.